{"id":2078,"date":"2026-07-16T06:00:00","date_gmt":"2026-07-15T21:00:00","guid":{"rendered":"http:\/\/project-sbi.local\/ir-news\/sbi%ec%9d%b8%eb%b2%a0-%ed%8f%ac%ed%8a%b8%ed%8f%b4%eb%a6%ac%ec%98%a4-%eb%85%b8%eb%b3%b4%eb%a0%89%ec%8a%a4-ai-%ec%8b%a0%ec%95%bd%ea%b0%9c%eb%b0%9c-%ea%b8%b0%ec%88%a0%eb%a1%9c-%eb%b6%88%ec%b9%98\/"},"modified":"2026-10-22T17:01:30","modified_gmt":"2026-10-22T08:01:30","slug":"sbi-investment-portfolio-company-novorex-takes-on-parkinsons-an-incurable-diseas","status":"publish","type":"ir","link":"https:\/\/sbi13.dayworks.kr\/en\/ir-news\/sbi-investment-portfolio-company-novorex-takes-on-parkinsons-an-incurable-diseas\/","title":{"rendered":"SBI Investment Portfolio Company Novorex Takes on Parkinson&#8217;s, an \u2018Incurable Disease,\u2019 with AI Drug Discovery Technology\u2026 Featured in The Chosun Ilbo&#8217;s \u2018Startup Insight\u2019"},"content":{"rendered":"<ul>\n<li>Son Woo-sung, CEO of Novorex, an SBI Investment portfolio company developing small-molecule drugs using AI, was featured in an interview in The Chosun Ilbo&#039;s \u2018Startup Insight,\u2019 which highlighted the company&#039;s distinctive drug discovery methodology combining the speed of AI with biophysical validation.<\/li>\n<li>Novorex is developing \u2018NRX-NGT002,\u2019 a drug candidate targeting LRRK2, a key protein implicated in Parkinson&#039;s disease, as its lead pipeline, and has raised a cumulative KRW 44.6 billion from investors including SBI Investment.<\/li>\n<li>Accelerating development with the goal of submitting an Investigational New Drug (IND) application for a global Phase 1 trial within the year, the company is drawing attention as a K-bio innovation that could open a new path to treating Parkinson&#039;s, long considered incurable.<\/li>\n<\/ul>\n<p>The full article is available at the link below.<\/p>\n<p><a href=\"https:\/\/n.news.naver.com\/mnews\/article\/023\/0003987918?sid=101\" target=\"_blank\" rel=\"noopener\">https:\/\/n.news.naver.com\/mnews\/article\/023\/0003987918?sid=101<\/a><\/p>\n","protected":false},"featured_media":0,"template":"","ir_type":[40],"class_list":["post-2078","ir","type-ir","status-publish","hentry","ir_type-news-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/sbi13.dayworks.kr\/en\/wp-json\/wp\/v2\/ir\/2078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sbi13.dayworks.kr\/en\/wp-json\/wp\/v2\/ir"}],"about":[{"href":"https:\/\/sbi13.dayworks.kr\/en\/wp-json\/wp\/v2\/types\/ir"}],"wp:attachment":[{"href":"https:\/\/sbi13.dayworks.kr\/en\/wp-json\/wp\/v2\/media?parent=2078"}],"wp:term":[{"taxonomy":"ir_type","embeddable":true,"href":"https:\/\/sbi13.dayworks.kr\/en\/wp-json\/wp\/v2\/ir_type?post=2078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}